BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11592437)

  • 1. Heterogeneity of the association between plasma homocysteine and atherothrombotic disease: insights from studies of vascular structure and function.
    Stehouwer CD
    Clin Chem Lab Med; 2001 Aug; 39(8):705-9. PubMed ID: 11592437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.
    Stehouwer CD; Jakobs C
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can mild-to-moderate hyperhomocysteinaemia impair endothelial function in the absence of other risk factors for cardiovascular disease?
    Honing ML; Stehouwer CD
    Clin Sci (Lond); 2004 Apr; 106(4):345-6. PubMed ID: 14656217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina.
    Guo H; Chi J; Xing Y; Wang P
    Indian J Med Res; 2009 Mar; 129(3):279-84. PubMed ID: 19491420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
    Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D
    Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of vascular disease in hyperhomocysteinaemia.
    DomagaƂa TB; Undas A; Libura M; Szczeklik A
    J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
    Stehouwer DA
    Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
    Refai TM; Al-Salem IH; Nkansa-Dwamena D; Al-Salem MH
    Clin Rheumatol; 2002 Nov; 21(6):457-61. PubMed ID: 12447627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
    Stanger O; Weger M
    Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and large arteries.
    Guldener CV; Stehouwer CDA
    Adv Cardiol; 2007; 44():278-301. PubMed ID: 17075216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.
    Malerba M; Gisondi P; Radaeli A; Sala R; Calzavara Pinton PG; Girolomoni G
    Br J Dermatol; 2006 Dec; 155(6):1165-9. PubMed ID: 17107384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hyperhomocysteinaemia and endothelial dysfunction.
    Chambers JC; McGregor A; Jean-Marie J; Kooner JS
    Lancet; 1998 Jan; 351(9095):36-7. PubMed ID: 9433433
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.
    Mangoni AA; Sherwood RA; Asonganyi B; Swift CG; Thomas S; Jackson SH
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):220-6. PubMed ID: 15752950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinaemia and vascular disease.
    Townend J; O'Sullivan J; Wilde JT
    Blood Rev; 1998 Mar; 12(1):23-34. PubMed ID: 9597195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.